Analytical Data
-
基因名
TCHH
- Application
-
别名
TCHH；THH；THL；TRHY；Trichohyalin
-
种属
Human
-
表达系统
E. coli
-
标签
His tag N-Terminus
-
纯度
Greater than 90% as determined by SDS-PAGE.
-
蛋白编号
Q07283
-
表达区间
1854-1943aa
-
氨基酸序列
QEKSRREEQELWQEEEQKRRQERERKLREEHIRRQQKEEQRHRQVGEIKSQEGKGHGRLLEPGTHQFASVPVRSSPLYEYIQEQRSQYRP
-
分子量
18.6 kDa
-
内毒素
< 1.0 EU per μg protein as determined by the LAL method.
-
性状
Freeze-dried powder
-
缓冲液
PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300.
-
复溶方法
Reconstitute in ddH2O to a concentration of 0.1-0.5 mg/mL. Do not vortex.
- 个性化定制
-
稳定性测试
The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37℃ for 48h, and no obvious degradation and precipitation were observed. The loss rate isless than 8% within the expiration date under appropriate storage condition.
-
保存条件 & 期限
Samples are stable for up to twelve months from date of receipt at -20℃ to -80℃. Store it under sterile conditions at -20℃ to -80℃. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
-
运输条件
In general, recombinant proteins are supplied as lyophilized powder and shipped at ambient temperature. For bulk packages, the proteins are provided as frozen liquid and shipped with blue ice, unless otherwise requested by the customer.
Quality inspection process
Related Products
Protein Description
TCHH (Tachykinin-Related Peptide 1 Homolog) is a protein that belongs to a family of tachykinins, which are neuropeptides known for their roles in various physiological processes, including pain sensation, inflammation, and modulation of the immune response. Research into TCHH and its recombinant proteins has gained considerable attention due to its potential applications in therapeutic interventions. The protein is expressed in various tissues and is believed to engage in cell-signaling pathways, influencing numerous biological functions. Understanding TCHH's structure and function is crucial, as it might play a significant role in conditions like neurodegenerative diseases, where its dysregulation could have deleterious effects. The development of recombinant TCHH proteins allows researchers to explore its biological activity in detail, facilitating studies on its receptor interactions, signaling mechanisms, and potential as a biomarker. Additionally, the therapeutic potential of TCHH may include its use in pain management or as a target for drug development aimed at modulating the neuroimmune interactions. As a result, ongoing research focuses on elucidating the functional properties of TCHH, its expression patterns in various cell types, and the implications of its modulation in different disease contexts, which could pave the way for innovative therapeutic strategies.
